Currently Viewing:
Currently Reading
Insomnia Correlated to an Increased Risk of Heart Disease and Stroke, Study Shows
August 19, 2019 – Matthew Gavidia
Inspiratory Muscle Training May Be an Option for Patients Who Decline Pulmonary Rehabilitation for COPD
August 18, 2019 – Kelly Davio
Blood Clots in MPN Related to Higher Cost, Length of Stay for Patients With MPN
August 17, 2019 – AJMC Staff
Researchers Seek to Determine Genetic Variability in Parkinson Progression
August 17, 2019 – AJMC Staff
FDA Panel Backs Use of Descovy for HIV Prevention in Men, Transgender Women
August 16, 2019 – Jaime Rosenberg
Researcher Excited About Future of Psoriasis Treatment
August 16, 2019 – Allison Inserro
This Week in Managed Care: August 16, 2019
August 16, 2019
AJMC® in the Press, August 16, 2019
August 16, 2019 – AJMC Staff
Pediatric Leukemia Treatment Linked to Increased Risk of Infections, Study Finds
August 16, 2019 – Alison Rodriguez

Top 5 AJMC® Articles of July 2019

Here are the top 5 articles for the month of July.

Hi, this is Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of July.

Number 5: HHS announced the launch of 5 new payment models to improve kidney disease care. The proposed models would encourage greater use of home dialysis and kidney transplants in Medicare and to test new Medicare payment options for kidney disease care.

Number 4: The FDA has approved Eli Lilly’s nasal glucagon, the first such therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

Number 3: A study found that the amount of riboflavin, or vitamin B2, that someone consumes through their diet could have an impact on migraine. The findings revealed that study participants who consumed more riboflavin experienced reductions in migraine occurrence.

Number 2: A bipartisan group of senators introduced legislation that calls for cutting insulin prices up to 75%, which would give more patients with diabetes the ability to take the right dose and more families a chance to recover from years of rising out-of-pocket costs.

Number 1: By combining CRISPR and long-acting slow-effective release antiretroviral therapy, researchers were able to effectively eliminate HIV from the genomes of approximately 30% of infected mice.

To read all of these articles and more, visit

Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up